AI
BXC icon

Atria Investments’s BlueLinx BXC Stock Holding History

Atria Investments’s Portfolio BXC Stock Details BXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
+3,998
New +$262K ﹤0.01% 1943

Other funds holding BXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atria Investments's BXC Position: Q1 2026 in Review

Atria Investments opened a new position in BlueLinx (BXC) in Q1 2026: 3,998 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1943 among its holdings.

145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • Atria Investments held 3,998 shares of BlueLinx worth $217K as of Q1 2026.
  • BlueLinx was a new Atria Investments position in Q1 2026.
  • BlueLinx made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1943 holding.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.